trending Market Intelligence /marketintelligence/en/news-insights/trending/YNhOyn8Oj5jKBW_wYWHJMw2 content esgSubNav
In This List

Tandem Diabetes stockholders approve reverse stock split

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Tandem Diabetes stockholders approve reverse stock split

Tandem Diabetes Care, Inc. stockholders approved the implementation of a 1-for-10 reverse stock split of the company's issued and outstanding common stock.

Following the stock split, Tandem's issued and outstanding common stock will be about 5.5 million shares. The company's authorized common shares will remain at 100 million shares.

Tandem's common stock will trade on the Nasdaq Global Market on a split-adjusted basis beginning Oct. 10.

American Stock Transfer & Trust Co. LLC is acting as the exchange agent for the reverse stock split.